Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPA 30 mg before dominant follicle selection
NL-OMON42809Active, not recruiting
- Sponsor
- HRA Pharma
- Start
- Feb 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ulipristal in emergency contraception (EC), sponsored by HRA Pharma. Primary endpoints: Follicular growth during treatment cycle and Day of occurrence of ovulation during treatment cycle. Started Feb 2016; status: active, not recruiting.
02
Drugs
ulipristal
03
Conditions
emergency contraception (EC)
Beyond the preview
Go deeper on NL-OMON42809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42809.